About Todd Foley
Todd Foley is a director and 10% owner at Entrada Therapeutics.
Form D filings name Todd Foley as a director at Crossbow Therapeutics and Aktis Oncology.
Todd Foley reports to the SEC as a director, officer or major shareholder of 23 public companies, including Aktis Oncology (AKTS), iTeos Therapeutics (ITOS) and Werewolf Therapeutics (HOWL).
Todd Foley first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Todd Foley in the role, so the role may have started earlier or lasted longer.
EI
Entrada Therapeutics, Inc.
Director and 10% owner
2021 – 2026 · Public company (TRDA)
II
iTeos Therapeutics, Inc.
10% owner
2020 – 2025 · Public company (ITOS)
WI
Werewolf Therapeutics, Inc.
10% owner
2021 – 2025 · Public company (HOWL)
RI
Repare Therapeutics Inc.
Director and 10% owner
2020 – 2023 · Public company (RPTX)
TI
TCR2 Therapeutics Inc.
10% owner
2019 – 2023 · Public company (TCRR)
CI
Chiasma, Inc.
Director and 10% owner
2015 – 2021 · Public company (CHMA)
HI
Harpoon Therapeutics, Inc.
10% owner
2019 – 2021 · Public company (HARP)
RI
Rhythm Pharmaceuticals, Inc.
Director and 10% owner
2017 – 2021 · Public company (RYTM)
TC
Turmeric Acquisition Corp.
President
2020 · Public company (TMPM)
OI
Oncorus, Inc.
10% owner
2020 · Public company (ONCR)
DI
Dyne Therapeutics, Inc.
10% owner
2020 · Public company (DYN)
RI
Radius Health, Inc.
10% owner
2011 – 2016 · Public company (RDUS)
SI
Syndax Pharmaceuticals Inc
10% owner
2016 · Public company (SNDX)
AI
Avalo Therapeutics, Inc.
10% owner
2015 · Public company (AVTX)
TI
TriVascular Technologies, Inc.
10% owner
2014 · Public company (TRIV)
AI
Aratana Therapeutics, Inc.
10% owner
2013 – 2014 · Public company (PETX)
EI
Epizyme, Inc.
10% owner
2013 – 2014 · Public company (EPZM)
EI
Eiger BioPharmaceuticals, Inc.
Director
2014 · Public company (EIGR)
HI
Histogen Inc.
10% owner
2013 · Public company (HSTO)
PI
Pacira BioSciences, Inc.
10% owner
2011 – 2013 · Public company (PCRX)
EI
EPIRUS Biopharmaceuticals, Inc.
Director
2009 – 2012 · Public company (EPRS)
VI
Verastem, Inc.
Reporting person
2012 · Public company (VSTM)
Key Colleagues at Startups
The people Todd Foley works with at each company, as listed on that company's latest Form D.
Crossbow Therapeutics, Inc. · Form D, Sep 30, 2025
AN
Alexander Nolte
Executive officer
Alexandra Cantley
Director
DW
Dmitri Wiederschain
Executive officer
SA
Sakae Asanuma
Director
CB
Charles Baum
Director
Briggs Morrison
Chief Executive Officer and director
IM
Irena Melnikova
Director
AL
Alon Lazarus
Director
Aktis Oncology, Inc. · Form D, Oct 2, 2024
HK
Helen Kim
Director
SB
Shulamit Ron-Bigger
Executive officer
KH
Ken Herrmann
Director
LS
Lloyd Segal
Director
ON
Oleg Nodelman
Director
AL
Andrew Levin
Director
MR
Matthew Roden
CEO and director